Comparison of TACE alone versus TACE combined with synchronous ablation for neuroendocrine neoplasms with liver metastases
Simultaneous ablation can delay disease progression in patients with liver metastasis of neuroendocrine tumors to a certain extent, and has a good safety, especially for patients with liver metastases of neuroendocrine tumors of intermediate or low grade or pancreatic origin.
Authors
- Danyang Zhao (ORCID: https://orcid.org/0000-0002-5548-3367)
- Zhiping Yan (ORCID: https://orcid.org/0000-0002-9352-3526)
- Yav Sothea
- Lingxiao Liu (ORCID: https://orcid.org/0000-0003-3525-090X)
- Liang Liu (ORCID: https://orcid.org/0000-0002-6477-254X)
- Wen‐Quan Wang (ORCID: https://orcid.org/0000-0003-2957-0472)
- Yuan Ji (ORCID: https://orcid.org/0000-0001-7835-6662)
- Yi Chen (ORCID: https://orcid.org/0000-0002-9675-5998)
- Huiyi Sun
- Wang Feihang
- Huo Zihao
- Shuai Junqi
Institutions
- Shanghai Lixin University of Accounting and Finance (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Zhongshan Hospital (CN)
- Prek Leap National College of Agriculture (KH)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shanghai Institute of Hematology (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1007/s00432-025-06274-y
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Health Commission of the People's Republic of China